Post-Pandemic New Normal: China’s IVD Market Opportunities

The demand for IVD product due to the Covid-19 pandemic is expected to increase mainly due to factors as a sharp rise in market demand for PCR, NGS products, the supportive regulatory landscape for product development & commercialization, and a sharp rise in target patient population. The Chinese market is expected to reach almost 200 billion USD

Coronavirus COVID-19, The Opportunities in AI & Robotics

The Coronavirus Covid-19 has been sweeping the world since the end of 2019. The supply chain industry connected to the global economy has been greatly affected. However, the epidemic also brings different levels of opportunities and challenges to different industries. It is expected to accelerate the implementation of artificial intelligence scenarios and promote the development of unmanned factories and smart factories. Meanwhile for the epidemic situation and medical health, there will be more subdivided AI scenarios to land. The innovations in interdisciplinary fields such as medical, emotional, social, and artificial intelligence will create a new series of products and applications.


Key2China was invited by the organizer to attend the first Global Health Forum of Boao Forum for Asia in Qingdao, Shandong Province. 14 European deep tech companies on medical devices, pharmaceuticals were presented to the medical and healthcare investors at the event. Global Health Forum of Boao Forum for Asia Aimed at gathering global consensus[…]